Factors influencing change of preoperative treatment intent in a gastrointestinal cancer practice

Por Schwarz, Roderich E
Publicado em 2007

Collision tumor in form of primary adenocarcinoma and neuroendocrine carcinoma of the duodenum

Por Peng, Lan, Schwarz, Roderich E.
Publicado em 2012

Profile of nintedanib in the treatment of solid tumors: the evidence to date

Por Awasthi, Niranjan, Schwarz, Roderich E
Publicado no Onco Targets Ther (2015)

Vascular challenges from pancreatoduodenectomy in the setting of coeliac artery stenosis

Por Beane, Joal D, Schwarz, Roderich E
Publicado no BMJ Case Rep (2017)

Proteasome inhibition enhances antitumour effects of gemcitabine in experimental pancreatic cancer

Por Awasthi, Niranjan, Schwarz, Margaret A, Schwarz, Roderich E
Publicado em 2009

Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer

Por Awasthi, Niranjan, Schwarz, Margaret A, Schwarz, Roderich E
Publicado em 2011

Pancreatoduodenectomy with or without Pyloric Preservation: A Clinical Outcomes Comparison

Por Dineen, Sean P., Roland, Christina L., Schwarz, Roderich E.
Publicado em 2008

AHPBA/SSO/SSAT Sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma

Por Dixon, Elijah, Abdalla, Eddie, Schwarz, Roderich E, Vauthey, Jean-Nicolas
Publicado em 2010

The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer

Por ZHANG, CHANG-HUA, AWASTHI, NIRANJAN, SCHWARZ, MARGARET A., SCHWARZ, RODERICH E.
Publicado em 2013

Cell Proliferation and Migration Are Modulated by Cdk-1-Phosphorylated Endothelial-Monocyte Activating Polypeptide II

Por Schwarz, Margaret A., Thornton, Janet, Xu, Haiming, Awasthi, Niranjan, Schwarz, Roderich E.
Publicado em 2012

Evaluation of Poly-Mechanistic Antiangiogenic Combinations to Enhance Cytotoxic Therapy Response in Pancreatic Cancer

Por Awasthi, Niranjan, Zhang, Changhua, Ruan, Winston, Schwarz, Margaret A., Schwarz, Roderich E.
Publicado em 2012

Superior Antitumor Activity of Nanoparticle Albumin-Bound Paclitaxel in Experimental Gastric Cancer

Por Zhang, Changhua, Awasthi, Niranjan, Schwarz, Margaret A., Hinz, Stefan, Schwarz, Roderich E.
Publicado em 2013

Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II

Por Awasthi, Niranjan, Zhang, Changhua, Hinz, Stefan, Schwarz, Margaret A, Schwarz, Roderich E
Publicado em 2013

AHPBA/SSO/SSAT sponsored consensus conference on the multidisciplinary treatment of colorectal cancer metastases

Por Schwarz, Roderich E, Abdalla, Eddie K, Aloia, Thomas A, Vauthey, Jean-Nicolas
Publicado em 2013

The N Terminus of Pro-endothelial Monocyte-activating Polypeptide II (EMAP II) Regulates Its Binding with the C Terminus, Arginyl-tRNA Synthetase, and Neurofilament Light Protein

Por Xu, Haiming, Malinin, Nikolay L., Awasthi, Niranjan, Schwarz, Roderich E., Schwarz, Margaret A.
Publicado no J Biol Chem (2015)

Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer

Por Awasthi, Niranjan, Hinz, Stefan, Brekken, Rolf A., Schwarz, Margaret A., Schwarz, Roderich E.
Publicado no Cancer Lett (2014)

Enhancement of Nab-Paclitaxel Antitumor Activity through Addition of Multitargeting Antiangiogenic Agents in Experimental Pancreatic Cancer

Por Awasthi, Niranjan, Zhang, Changhua, Schwarz, Anna M., Hinz, Stefan, Schwarz, Margaret A., Schwarz, Roderich E.
Publicado no Mol Cancer Ther (2014)

Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer

Por Awasthi, Niranjan, Kirane, Amanda, Schwarz, Margaret A, Toombs, Jason E, Brekken, Rolf A, Schwarz, Roderich E
Publicado em 2011

Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models

Por Awasthi, Niranjan, Scire, Emily, Monahan, Sheena, Grojean, Meghan, Zhang, Eric, Schwarz, Margaret A., Schwarz, Roderich E.
Publicado no Oncotarget (2016)

A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma

Por Hassan, Md. Sazzad, Awasthi, Niranjan, Li, Jun, Schwarz, Margaret A., Schwarz, Roderich E., von Holzen, Urs
Publicado no PLoS One (2017)